107 related articles for article (PubMed ID: 3046973)
21. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
Rossetti L; Shulman GI; Zawalich WS
Diabetes; 1987 Oct; 36(10):1212-5. PubMed ID: 3308589
[TBL] [Abstract][Full Text] [Related]
22. The effect of monooleoylglycerol on insulin secretion from isolated perifused rat islets.
Zawalich WS; Zawalich KC; Rasmussen H
Diabetologia; 1989 Jun; 32(6):360-4. PubMed ID: 2668083
[TBL] [Abstract][Full Text] [Related]
23. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
[TBL] [Abstract][Full Text] [Related]
24. Effects of short-term culturing on islet phosphoinositide and insulin secretory responses to glucose and carbachol.
Zawalich WS; Zawalich KC; Kelley GG
Acta Diabetol; 1995 Oct; 32(3):158-64. PubMed ID: 8590784
[TBL] [Abstract][Full Text] [Related]
25. Effects of L-364,718 on pancreatic exocrine and endocrine secretion in the rat.
Nakamura T; Fujii M; Okabayashi Y; Tani S; Fujisawa T; Koide M; Otsuki M
Pancreas; 1990 Mar; 5(2):216-21. PubMed ID: 1690422
[TBL] [Abstract][Full Text] [Related]
26. Influence of pyruvic acid methyl ester on rat pancreatic islets. Effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell.
Zawalich WS; Zawalich KC
J Biol Chem; 1997 Feb; 272(6):3527-31. PubMed ID: 9013600
[TBL] [Abstract][Full Text] [Related]
27. Time-dependent effects of cholinergic stimulation on beta cell responsiveness.
Zawalich WS; Zawalich KC; Kelley GG
Pflugers Arch; 1996 Aug; 432(4):589-96. PubMed ID: 8764958
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin is not a major determinant for the changes in beta-cell function seen after pancreatico-biliary diversion in rats.
Gasslander T; Lilja I; Smeds S; Lundquist I; Ihse I
Diabetes Res; 1991 Nov; 18(3):135-42. PubMed ID: 1841824
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of monomethylsuccinate and glucose on insulin secretion from perifused rat islets.
Zawalich WS; Zawalich KC; Cline G; Shulman G; Rasmussen H
Diabetes; 1993 Jun; 42(6):843-50. PubMed ID: 8388341
[TBL] [Abstract][Full Text] [Related]
30. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Karlsson S; Ahrén B
Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
[TBL] [Abstract][Full Text] [Related]
31. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
[TBL] [Abstract][Full Text] [Related]
32. Phosphoinositide hydrolysis and insulin release from isolated perifused rat islets. Studies with glucose.
Zawalich WS; Zawalich KC
Diabetes; 1988 Sep; 37(9):1294-300. PubMed ID: 2842212
[TBL] [Abstract][Full Text] [Related]
33. Dependence on extracellular Ca2+ for the effects of cholecystokinin-8 in rat pancreatic islets.
Karlsson S; Ahrén B
Diabetes Res; 1991 Mar; 16(3):139-43. PubMed ID: 1666346
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 1 inhibits insulin secretion from isolated perifused rat islets.
Zawalich WS; Diaz VA
Diabetes; 1986 Oct; 35(10):1119-23. PubMed ID: 3530842
[TBL] [Abstract][Full Text] [Related]
35. Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol.
Simonsson E; Karlsson S; Ahrén B
Diabetes; 1998 Sep; 47(9):1436-43. PubMed ID: 9726232
[TBL] [Abstract][Full Text] [Related]
36. Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets. A study on phospholipase C activity and calcium requirement.
Malm D; Giaever A; Vonen B; Florholmen J
Scand J Clin Lab Invest; 1993 Nov; 53(7):671-6. PubMed ID: 7903820
[TBL] [Abstract][Full Text] [Related]
37. Influence of cholecystokinin on insulin output from isolated perifused pancreatic islets.
Zawalich WS; Cote SB; Diaz VA
Endocrinology; 1986 Aug; 119(2):616-21. PubMed ID: 3525123
[TBL] [Abstract][Full Text] [Related]
38. Cholinergic agonists prime the beta-cell to glucose stimulation.
Zawalich WS; Zawalich KC; Rasmussen H
Endocrinology; 1989 Nov; 125(5):2400-6. PubMed ID: 2676484
[TBL] [Abstract][Full Text] [Related]
39. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
[TBL] [Abstract][Full Text] [Related]
40. Phosphoinositide metabolism and insulin secretion from isolated rat pancreatic islets.
Clements RS; Rhoten WB
J Clin Invest; 1976 Mar; 57(3):684-91. PubMed ID: 175090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
